These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15161003)

  • 1. Effects of oral squamous cell carcinoma-derived TGF-beta1 on CD26/DPPIV expression in T cells.
    Uematsu T; Tanaka H; Yamaoka M; Furusawa K
    Anticancer Res; 2004; 24(2B):619-24. PubMed ID: 15161003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.
    Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
    J Immunol; 1996 Mar; 156(5):1714-21. PubMed ID: 8596018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of migratory potential in human peritoneal mesothelial cells.
    Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
    Cell Tissue Res; 2007 Nov; 330(2):221-9. PubMed ID: 17846797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases.
    Takayama S; Hatori M; Kurihara Y; Kinugasa Y; Shirota T; Shintani S
    Oncol Rep; 2009 Jan; 21(1):205-10. PubMed ID: 19082463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and glucocorticoids differentially regulate APN/CD13 and DPPIV/CD26 enzyme activities in cultured human dermal fibroblasts.
    Sorrell JM; Brinon L; Baber MA; Caplan AI
    Arch Dermatol Res; 2003 Aug; 295(4):160-8. PubMed ID: 12861419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells.
    Kajiyama H; Kikkawa F; Khin E; Shibata K; Ino K; Mizutani S
    Cancer Res; 2003 May; 63(9):2278-83. PubMed ID: 12727850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines.
    Ahn YO; Lee JC; Sung MW; Heo DS
    J Immunol; 2009 May; 182(10):6114-20. PubMed ID: 19414763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
    Goscinski MA; Suo ZH; Nesland JM; Chen WT; Zakrzewska M; Wang J; Zhang S; Flørenes VA; Giercksky KE
    Oncology; 2008; 75(1-2):49-59. PubMed ID: 18787344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes.
    Salgado FJ; Vela E; Martín M; Franco R; Nogueira M; Cordero OJ
    Cytokine; 2000 Jul; 12(7):1136-41. PubMed ID: 10880264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia.
    de Andrade CF; Bigni R; Pombo-de-Oliveira MS; Alves G; Pereira DA
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):708-14. PubMed ID: 19469710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
    Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
    Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
    Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
    Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of transforming growth factor-beta1 on EDA region of fibronectin in oral squamous cell carcinoma and adenoid cystic carcinoma cells].
    Zhang JP; Li CY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):47-51. PubMed ID: 17331445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines regulate membrane adenosine deaminase on human activated lymphocytes.
    Cordero OJ; Salgado FJ; Fernández-Alonso CM; Herrera C; Lluis C; Franco R; Nogueira M
    J Leukoc Biol; 2001 Dec; 70(6):920-30. PubMed ID: 11739555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1).
    Arndt M; Lendeckel U; Spiess A; Faust J; Neubert K; Reinhold D; Ansorge S
    Biochem Biophys Res Commun; 2000 Aug; 274(2):410-4. PubMed ID: 10913352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.